107 related articles for article (PubMed ID: 29166807)
21. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
[TBL] [Abstract][Full Text] [Related]
22. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
23. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
24. Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
Matoso A; Epstein JI
Am J Surg Pathol; 2015 Oct; 39(10):1377-82. PubMed ID: 25929352
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 31 ankylosing spondylitis patients with malignancies].
Gao L; Fan Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):962-5. PubMed ID: 26679658
[TBL] [Abstract][Full Text] [Related]
26. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
27. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.
Shinagare AB; Ramaiya NH; Jagannathan JP; Fennessy FM; Taplin ME; Van den Abbeele AD
AJR Am J Roentgenol; 2011 Jan; 196(1):117-22. PubMed ID: 21178055
[TBL] [Abstract][Full Text] [Related]
28. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
29. FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
Wang H; Hoda RS; Faquin W; Rossi ED; Hotchandani N; Sun T; Pusztaszeri M; Bizzarro T; Bongiovanni M; Patel V; Jhala N; Fadda G; Gong Y
Cancer Cytopathol; 2017 Feb; 125(2):91-103. PubMed ID: 28001329
[TBL] [Abstract][Full Text] [Related]
30. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases.
Bates AW; Baithun SI
Histopathology; 2000 Jan; 36(1):32-40. PubMed ID: 10632749
[TBL] [Abstract][Full Text] [Related]
31. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
Zhang M; Wah C; Epstein JI
Am J Surg Pathol; 2014 Nov; 38(11):1516-21. PubMed ID: 25140895
[TBL] [Abstract][Full Text] [Related]
32. Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases.
Matsumoto K; Hayakawa N; Nakamura S; Oya M
Clin Exp Metastasis; 2015 Feb; 32(2):135-41. PubMed ID: 25630270
[TBL] [Abstract][Full Text] [Related]
33. Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas.
Menon S; Goyal P; Suryawanshi P; Tongaonkar H; Joshi A; Bakshi G; Desai S
Indian J Pathol Microbiol; 2014; 57(1):19-23. PubMed ID: 24739826
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
35. Serous adenocarcinoma of the uterus metastatic to the urinary bladder mimicking primary bladder neoplasia. A report of a case.
Young RH; Johnston WH
Am J Surg Pathol; 1990 Sep; 14(9):877-80. PubMed ID: 2389818
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
38. Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.
Gordetsky J; Collingwood R; Lai WS; Del Carmen Rodriquez Pena M; Rais-Bahrami S
Int J Surg Pathol; 2018 Feb; 26(1):12-17. PubMed ID: 28905666
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
[TBL] [Abstract][Full Text] [Related]
40. [Metastatic tumors in the ovary, difficulties of histologic diagnosis].
Tamás J; Vereczkey I; Tóth E
Magy Onkol; 2015 Sep; 59(3):205-13. PubMed ID: 26339910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
